• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非高密度脂蛋白胆固醇而非低密度脂蛋白胆固醇作为脂蛋白胆固醇筛查、风险评估及治疗工具的理论依据。

Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.

作者信息

Frost P H, Havel R J

机构信息

Cardiovascular Research Institute and Department of Medicine, University of California, San Francisco 94143-0326, USA.

出版信息

Am J Cardiol. 1998 Feb 26;81(4A):26B-31B. doi: 10.1016/s0002-9149(98)00034-4.

DOI:10.1016/s0002-9149(98)00034-4
PMID:9526810
Abstract

The plasma level of low-density lipoprotein (LDL) cholesterol is the "gold standard" for estimating the lipoprotein-related risk for complications of atherosclerotic vascular disease. LDL cholesterol concentrations are commonly estimated by the Friedewald formula that requires only the measurement (after overnight fasting) of plasma cholesterol and triglycerides along with high-density lipoprotein (HDL) cholesterol. This value, however, is not in fact a true estimate of LDL cholesterol but rather of LDL cholesterol along with variable, usually smaller, amounts of intermediate-density lipoprotein (IDL) cholesterol and lipoprotein(a). Estimation of LDL cholesterol levels by the Friedewald formula becomes progressively less accurate as plasma triglyceride concentrations increase, and the formula is generally considered inapplicable when triglyceride levels exceed 400 mg/dL. We believe that a very simple measurement-non-HDL cholesterol (serum cholesterol minus HDL cholesterol)-has considerable potential as a screening tool for identifying dyslipoproteinemias, for risk assessment, and for assessing the results of hypolipidemic therapy. Unlike the estimation of LDL cholesterol levels by the Friedewald formula, the estimation of non-HDL cholesterol concentrations requires no assumptions about the relation of very-low-density (VLDL) cholesterol levels to plasma triglyceride concentrations. This method includes all of the cholesterol present in lipoprotein particles now considered to be potentially atherogenic [VLDL, IDL, LDL, and lipoprotein(a)]. This article provides examples of the utility of non-HDL cholesterol concentrations in clinical medicine.

摘要

低密度脂蛋白(LDL)胆固醇的血浆水平是评估动脉粥样硬化性血管疾病并发症的脂蛋白相关风险的“金标准”。LDL胆固醇浓度通常通过Friedewald公式估算,该公式仅需要(过夜禁食后)测量血浆胆固醇、甘油三酯以及高密度脂蛋白(HDL)胆固醇。然而,该值实际上并非LDL胆固醇的真实估算值,而是LDL胆固醇以及可变的、通常较少的中密度脂蛋白(IDL)胆固醇和脂蛋白(a)的估算值。随着血浆甘油三酯浓度的增加,通过Friedewald公式估算LDL胆固醇水平的准确性逐渐降低,当甘油三酯水平超过400mg/dL时,该公式通常被认为不适用。我们认为,一种非常简单的测量方法——非HDL胆固醇(血清胆固醇减去HDL胆固醇)——作为一种筛查工具,在识别血脂异常、风险评估以及评估降脂治疗效果方面具有很大潜力。与通过Friedewald公式估算LDL胆固醇水平不同,估算非HDL胆固醇浓度无需对极低密度脂蛋白(VLDL)胆固醇水平与血浆甘油三酯浓度之间的关系进行假设。该方法包括现在被认为可能具有致动脉粥样硬化作用的脂蛋白颗粒中存在的所有胆固醇[VLDL、IDL、LDL和脂蛋白(a)]。本文提供了非HDL胆固醇浓度在临床医学中的应用实例。

相似文献

1
Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.使用非高密度脂蛋白胆固醇而非低密度脂蛋白胆固醇作为脂蛋白胆固醇筛查、风险评估及治疗工具的理论依据。
Am J Cardiol. 1998 Feb 26;81(4A):26B-31B. doi: 10.1016/s0002-9149(98)00034-4.
2
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.马丁/霍普金斯估计、弗里德瓦尔德估计和制备超速离心法评估低密度脂蛋白胆固醇的比较: FOURIER 试验的见解。
JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533.
3
Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.轻度至中度升高的甘油三酯对高密度脂蛋白胆固醇水平低的健康男性低密度脂蛋白亚组分浓度及组成的影响。
Atherosclerosis. 1999 Mar;143(1):185-92. doi: 10.1016/s0021-9150(98)00278-0.
4
Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.氟伐他汀对高胆固醇血症患者中密度脂蛋白(残粒)及其他脂蛋白水平的影响。
Am J Cardiol. 1995 Jul 13;76(2):129A-135A. doi: 10.1016/s0002-9149(05)80035-9.
5
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.接受血液透析治疗的慢性肾衰竭患者在无高脂血症情况下的致动脉粥样硬化脂蛋白变化。
Atherosclerosis. 1997 Jun;131(2):229-36. doi: 10.1016/s0021-9150(97)00054-3.
6
Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.Friedewald 估计值与直接测量的低密度脂蛋白胆固醇及治疗意义。
J Am Coll Cardiol. 2013 Aug 20;62(8):732-9. doi: 10.1016/j.jacc.2013.01.079. Epub 2013 Mar 21.
7
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.肝脂肪酶在血液透析患者中密度脂蛋白及小而密低密度脂蛋白形成中的作用
Kidney Int Suppl. 1999 Jul;71:S227-8. doi: 10.1046/j.1523-1755.1999.07159.x.
8
Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.
Clin Chem. 1990 Jan;36(1):15-9.
9
Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients.非高密度脂蛋白胆固醇在血液透析患者中的效用
Metabolism. 2004 Aug;53(8):1013-5. doi: 10.1016/j.metabol.2004.01.001.
10
Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.非诺贝特和依折麦布单药治疗及联合用药对混合型高脂血症患者脂蛋白亚组分内胆固醇质量和低密度脂蛋白峰值粒径的影响。
Metabolism. 2008 Jun;57(6):796-801. doi: 10.1016/j.metabol.2008.01.026.

引用本文的文献

1
Emerging Predictors by Non-HDL-C/HDL-C Ratio and Novel Biomarkers for Coronary Slow Flow Phenomenon.基于非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值及新型生物标志物的冠状动脉慢血流现象的新兴预测指标
Acta Cardiol Sin. 2024 Jul;40(4):367-372. doi: 10.6515/ACS.202407_40(4).20240624A.
2
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.从儿童期到成年期的非高密度脂蛋白胆固醇水平与心血管疾病事件。
JAMA. 2024 Jun 4;331(21):1834-1844. doi: 10.1001/jama.2024.4819.
3
Adherence to a healthy lifestyle behavior composite score and cardiometabolic risk factors in Spanish children from the CORALS cohort.
在 CORALS 队列中,西班牙儿童健康生活方式行为综合评分与心血管代谢危险因素的关系。
Eur J Pediatr. 2024 Apr;183(4):1819-1830. doi: 10.1007/s00431-023-05389-z. Epub 2024 Jan 23.
4
Direct LDL Cholesterol Assay vs. Estimated Equations in Patients With Hypertriglyceridemia or Low LDL Cholesterol Levels.高甘油三酯血症或低密度脂蛋白胆固醇水平低的患者中直接低密度脂蛋白胆固醇检测与估算方程的比较
Ann Lab Med. 2024 Jul 1;44(4):363-366. doi: 10.3343/alm.2023.0387. Epub 2024 Jan 19.
5
PFAS levels in paired drinking water and serum samples collected from an exposed community in Central North Carolina.北卡罗来纳州中北部一个暴露社区采集的饮用水和血清配对样本中的全氟和多氟烷基物质水平。
Sci Total Environ. 2023 Oct 15;895:165091. doi: 10.1016/j.scitotenv.2023.165091. Epub 2023 Jun 23.
6
Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study.在黎巴嫩长期人道主义危机中用于心血管疾病的固定剂量复方药物:一项实施研究。
BMJ Open. 2023 Jan 25;13(1):e063668. doi: 10.1136/bmjopen-2022-063668.
7
Effect of High-Intensity Strength and Endurance Training in the Form of Small Circuits on Changes in Lipid Levels in Men Aged 35-40 Years.以小循环形式进行的高强度力量与耐力训练对35 - 40岁男性血脂水平变化的影响
J Clin Med. 2022 Aug 31;11(17):5146. doi: 10.3390/jcm11175146.
8
Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.他汀类药物对糖尿病和心血管疾病风险人群中非高密度脂蛋白胆固醇的疗效比较:系统评价和网络荟萃分析。
BMJ. 2022 Mar 24;376:e067731. doi: 10.1136/bmj-2021-067731.
9
β-hydroxy-β-methylbutyrate supplementation benefits the effects of resistance training on body fat reduction via increased irisin expression in white adipose tissue.补充β-羟基-β-甲基丁酸通过增加白色脂肪组织中鸢尾素的表达,有益于抗阻训练对减少体脂的作用。
Biol Sport. 2021 Mar;38(1):113-121. doi: 10.5114/biolsport.2020.97671. Epub 2020 Aug 21.
10
To fast or not to fast: Lipid measurement and cardiovascular disease risk estimation in rural sub-Saharan Africa.是否禁食:撒哈拉以南非洲农村地区的血脂测量和心血管疾病风险评估。
J Glob Health. 2020 Jun;10(1):010407. doi: 10.7189/jogh.10.010407.